Saturday, November 26, 2022
HomeBusiness NewsICL invests $10m in ag-biological co Lavie Bio

ICL invests $10m in ag-biological co Lavie Bio


Israeli specialty minerals firm ICL (TASE: ICL: NYSE: ICL) has introduced a $10 million funding in Israeli agritech firm Evogene (TASE: EVGN; Nasdaq: EVGN) ag-biological startup Lavie Bio. The funding is a part of a multi-year, strategic, collaboration settlement between ICL and Lavie Bio.







Lavie Bio seeks to enhance meals high quality, sustainability and agriculture productiveness via the introduction of microbiome-based merchandise. The corporate makes use of Evogene’s utilized computational predictive biology tech engine MicroBoost AI, leveraging big-data, superior synthetic intelligence (AI), together with a deep understanding of biology.

ICL’s $10 million SAFE (easy settlement for future fairness) funding in Lavie Bio will probably be made by way of ICL Planet Startup Hub, which is the platform ICL makes use of to spend money on and collaborate with progressive corporations in foodtech and agritech.

The collaboration will give attention to growing novel bio-stimulant merchandise to complement fertilizer effectivity.

ICL Progressive Ag Options president Elad Aharonson mentioned, “ICL is dedicated to creating impactful options for humanity’s sustainability challenges within the international meals, agriculture and industrial markets, and this collaboration with Lavie Bio very a lot resonates with our sustainability targets and values. The collaboration demonstrates ICL’s dedication to bringing to market new, sustainable applied sciences for our prospects. It additionally supplies us with a robust platform to enter the ag-biologicals market, which we see as extremely complementary to our current agriculture enterprise. Following an in depth analysis of Lavie Bio’s technical capabilities, we enthusiastically look ahead to collaborating with them to carry a lot wanted novel ag-biological merchandise to the worldwide market.”

Evogene president and CEO and Lavie Bio chairman Ofer Haviv added, “Collectively, we’ve got vital potential to develop novel ag-biologicals, that are anticipated to permit for the advance of world meals high quality, agricultural sustainability and productiveness, particularly in a time of meals shortage, excessive costs and macroeconomic uncertainty.”

Printed by Globes, Israel enterprise information – en.globes.co.il – on August 17, 2022.

© Copyright of Globes Writer Itonut (1983) Ltd., 2022.


RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments